SPDEF and benign prostatic hyperplasia: This study aimed to evaluate the methylation status of a specific CpG dinucleotide within the SPDEF (SAM-pointed domain-containing ETS transcription factor) gene promoter in blood leukocytes of PCa patients, using benign prostatic hyperplasia (BPH) samples as a control group.